medicine 📍 IN

Stimu-Let Tablet

178,72 ₹

Analogs of Stimu-Let Tablet

Find cheaper analogs and generic equivalents for Stimu-Let Tablet.

Ingredients

Substancja czynna: Letrozole

Przegląd produktu

About Stimu-Let Tablet

Stimu-Let Tablet is a medication containing the active ingredient Letrozole, classified as Aromatase Inhibitor. Letrozole, sold under the brand name Femara among others, is an aromatase inhibitor medication that is used in the treatment of breast cancer for post-menopausal women.

Key Benefits & Uses

Used for: 1 INDICATIONS AND USAGE Letrozole tablet is an aromatase inhibitor indicated for: Adjuvant treatment of postmenopausal women with hormone receptor.
Use only as directed on the product label or by a healthcare professional.
Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

Letrozole, the active ingredient in Stimu-Let Tablet, belongs to the Aromatase Inhibitor class. 1 INDICATIONS AND USAGE Letrozole tablet is an aromatase inhibitor indicated for: Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer ( 1. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Stimu-Let Tablet. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Stimu-Let Tablet for extended periods without medical advice.